πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 710 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11246937

One-step processing of hydrogels for mechanically robust and chemically desired features

The Board of Regents of the University of Texas System Β· Granted Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11229684

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a s

Rani Therapeutics, LLC Β· Granted Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11224645

Glycoconjugate vaccine for leishmaniasis

The Board of Regents of the University of Texas System Β· Granted Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11197883

Inhibition of stress granule formation through manipulation of UBAP2L

The Regents of the University of California Β· Granted Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11186533

Chalcone compound and preparation method thereof

SOUTH CHINA BOTANICAL GARDEN, CHINESE ACADEMY OF SCIENCES Β· Granted Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11178860

Humanized C5 animals

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11172694

Core-shell structure with titanium dioxide core

SOLID CHEMICALS GMBH Β· Granted Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11160859

Materials and methods for respiratory disease control in canines

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11149000

Carbamoyl phenylalaninol compounds and uses thereof

Jazz Pharmaceuticals Ireland Limited Β· Granted Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11149073

ROR1-specific chimeric antigen receptors (CAR) with humanized targeting domains

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11110139

Application of anthocyanin extract in preparing pharmaceutical composition for preventing

Northwest Institute of Plateau Biology, Chinese Academy of Sciences Β· Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11103479

Small organic molecules for use in the treatment of neuroinflammatory disorders

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center Β· Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11102961

Non-human animals having a humanized lymphocyte-activation gene 3

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11091761

Organic compositions to treat HSF1-related diseases

Arrowhead Pharmaceuticals, Inc. Β· Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11090349

Plant extract obtained from Morus plant leaves, compositions containing same, method of ex

Botanic Century (Beijing) Co. Ltd. Β· Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11064685

Non-human animal models of retinoschisis

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11066667

Organic compositions to treat APOC3-related diseases

Arrowhead Pharmaceuticals, Inc. Β· Granted Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11045493

Synthetic melanin nanoparticles and uses thereof

The Regents of the University of California Β· Granted Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11026998

Shaped mass composition comprising exenatide

Rani Therapeutics, LLC Β· Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11021542

Humanized BCMA antibody and BCMA-CAR-T cells

Caribou Biosciences, Inc. Β· Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11019810

Non-human animals having a humanized signal-regulatory protein gene

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11020495

Humanized low affinity FCΞ³R mouse cells

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11013220

Humanized dipeptidyl-peptidase IV (DPP4) animals

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11008553

Halogenation of complex organic compounds

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted